kabutan

TSUMURA & CO.(4540) Summary

4540
TSE Prime
TSUMURA & CO.
3,700.0
JPY
+8.0
(+0.22%)
Apr 28, 3:30 pm JST
23.24
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
11.3
PBR
0.90
Yield
3.89%
Margin Trading Ratio
6.74
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
3,722.0 JPY 23.35 USD
Previous Close Apr 27
3,692.0 JPY 23.16 USD
High Apr 28, 9:00 am
3,728.0 JPY 23.39 USD
Low Apr 28, 9:26 am
3,630.0 JPY 22.78 USD
Volume
350,500
Trading Value
1.29B JPY 8.11M USD
VWAP
3682.3 JPY 23.13 USD
Minimum Trading Value
370,000 JPY 2,324 USD
Market Cap
0.28T JPY 1.79B USD
Number of Trades
1,034
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
1,404
1-Year High May 13, 2025
8,192
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 57,500 150,300 2.61
Apr 17, 2026 55,800 140,700 2.52
Apr 10, 2026 57,400 128,400 2.24
Apr 3, 2026 57,200 130,200 2.28
Mar 27, 2026 56,800 124,000 2.18
Company Profile
TSUMURA & CO. is the leading company specializing in Kampo medicines, expanding its focus on medications for the elderly, cancer patients, and women's health. The company is also developing its business in China.
Sector
Pharmaceuticals
TSUMURA & CO. primarily engages in the manufacture and sale of Kampo medicines, offering both prescription and over-the-counter pharmaceuticals. The company has established an integrated production system from the cultivation of raw medicinal herbs to product manufacturing, ensuring thorough quality control. In Japan, TSUMURA & CO. has secured its position as the undisputed top manufacturer of prescription Kampo preparations. In recent years, the company has been actively expanding into the Chinese market, strengthening its local production and sales capabilities through capital and business alliances with local enterprises. Furthermore, TSUMURA & CO. is advancing its global business operations, including drug development in the United States and cultivation of raw medicinal herbs in Laos. The company focuses on promoting Kampo medicine and developing evidence-based Kampo preparations to address the diversifying needs in healthcare.